› Forums › General Melanoma Community › 2 Years NED, Kind of
- This topic has 8 replies, 8 voices, and was last updated 5 years, 7 months ago by
MelMel.
- Post
-
- August 8, 2019 at 2:14 pm
After starting with 7 tumors in my lungs in 2016 I had scans last week and have been NED for 2 years now but in July I did have a melanoma spot removed from my right arm, in SITU. Had second surgery to remove more even though I had 1.5 mm clear margins in the biopsy. I feel bad for posting this as so many on here are going through tough times now but at the same time I want to show there is hope and for some the ipi/nivo does work and fear not the side effects as they are better than melanoma. It has been 1 year since I completed 57 treatments, 5 combo and 52 nivo, and I am still dealing with side effects but no melanoma.
Viewing 7 reply threads
- Replies
-
-
- August 8, 2019 at 4:46 pm
Hukill,
It has been a year since I completed my ipi/nivo treatments after being on it a year. I was convinced the side effects were just something I was going to have to deal with for the rest of my life, but have noticed a significant improvement over the last 6 weeks or so. -
- August 8, 2019 at 7:38 pm
Thank you for this post
I’m on Nivo mono at present and they just removed a bit of Mel from my arm near the original scar. It’s been bothering me a lot and with scans in a few weeks have been quite stressed. This gives me some more hope so thank you
Really pleased for you as well keep up the good work – those in the trenches need some good news every now and again!
Cheers
Mark -
- August 9, 2019 at 5:28 am
Hip Hip! Huraay! Hip Hip! Thats badass Hukill! Theres Hope! And thank you for posting every so often, theres always New folks signing on here to MRF newly diagnosed, scared & even Scared (nervous) to start Immunal Therapies like you just completed! They need to read your posts the most! Please send a message to StudioDad he needs some encouraging for immunal weapons of war!
Good to hear from ya!!
Viewing 7 reply threads
- You must be logged in to reply to this topic.